PRKAA1 and thymus lymphoma: The failure of metformin to provide protection correlated with its inability to activate AMPK in thymic lymphomas, most likely because of the lack of expression of transporters, such as OCT1; expression of OCT1 family members was not detected in a previous proteomic analysis of PTEN-null T-ALL cells (Grzes et al., 2017).